Tuesday, May 2, 2017

Drug-maker Valeant on course to debt repayment target: CEO

Drug-maker Valeant on course to debt repayment target: CEO
By

LAVAL, Quebec (Reuters) - Valeant Pharmaceuticals International Inc , weighed down by debt from years of acquisitions, is on pace to meeting its target of repaying $5 billion in debt between August, 2016 and February, 2018, Chief Executive Joe Papa told shareholders on Tuesday.


May 2, 2017 at 10:11AM
via Reuters: Business News http://feeds.reuters.com/~r/reuters/businessNews/~3/-BjuyXlNFHw/us-valeantpharm-agm-idUSKBN17Y1NJ

No comments:

Post a Comment